Better Plant's Hand Sanitizer Gel Approved for Listing on Amazon.com
Vancouver, British Columbia--(Newsfile Corp. - October 6, 2020) - Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) is pleased to announce that Amazon.com has approved the listing for its Hand Sanitizer Gel, which is manufactured by its subsidiary, Urban Juve. The hand sanitizer gel is listed with the FDA (NDC 75385-0010-1) and has received Natural Health Product Number 80098154 from Health Canada. Urban Juve’s Ultra Hydrating Hand Sanitizer Spray received Health Canada approval on March 27, 2020. The Hand Sanitizer Gel will be live on Amazon.com later this month. Both the Hand Sanitizer Gel and Spray are available for purchase on Amazon.ca and urbanjuve.com.
Better Plant’s Hand Sanitizer Gel Approved for Listing on Amazon.com
To view an enhanced version of this graphic, please visit:
"The popularity of Amazon is undeniable," says Gabe Villablanca, Better Plant's Director of eCommerce. "During these times, it is becoming more and more simple and stress-free to shop online, so we want to expand that accessibility across the top platforms." Earlier this year, Urban Juve's full line went live on Amazon.ca, offering free shipping on orders over $35. Due to high demand, Urban Juve ensured the Hand Sanitizer Gel was the first product to be pushed through the approval process for Amazon.com. The Company plans to continue to use data to guide where they will make products available online for the convenience of consumers.
Based on a survey of more than 2,000 U.S. customers, 89 percent of buyers agree that they're more likely to buy products from Amazon than other eCommerce sites (Feedvisor, 2019).
About Better Plant Sciences Inc.
Better Plant develops and acquires intellectual property and other assets related to plant-based products and therapeutics. Through its integrated business model, Better Plant develops, manufactures, markets, sells and distributes plant-based products. It has over 200 proprietary wellness formulas at various stages of commercialization. It operates websites and sells through eCommerce, Amazon and through a retail store network over 150 plant based products for body, baby and home under the brands JUSU, Urban Juve and Wright & Well. Its majority-owned subsidiary NeonMind Biosciences Inc. is launching a line of coffees infused with health optimizing medicinal mushrooms including reishi, cordyceps, lion's mane and turkey tail mushrooms. NeonMind is also engaged in research into developing a psilocybin (psychedelic mushroom) based product for weight loss and has applied for Health Canada approval to begin preclinical trials to study its pending psychedelic medicine patents.
Investor Relations Contact:
Penny White, President & CEO
Kevan Matheson, Investor Relations
The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.
Cautionary Statement Regarding Forward-Looking Statements
This press release includes forward-looking information and statements (collectively, "forward looking statements") under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, brand development, availability of packaging, intellectual property protection, reduced global commerce and reduced access to raw materials and other supplies due to the spread of the Coronavirus, the potential for not acquiring any rights as a result of the patent application and any products making use of the intellectual property may be ineffective or the company may be unsuccessful in commercializing them; and other approvals will be required before commercial exploitation of the intellectual property can happen. Demand for the company's products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Better cautions readers not to place undue reliance on forward-looking statements provided by Better, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Better expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/65291